Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $7.29 USD
Change Today +0.0799 / 1.11%
Volume 112.0
EDGW On Other Exchanges
As of 9:42 AM 09/4/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Charles A. Sanders M.D.

AgeTotal Calculated CompensationThis person is connected to 156 board members in 12 different organizations across 19 different industries.

See Board Relationships


Dr. Charles A. Sanders, also known as Charlie, M.D., served as the Chief Executive Officer of Glaxo Inc. from July 1989 to July 1994 and as its Chairman of the Board from 1992 to May 1995. Dr. Sanders served as the Head, General Director, and Executive Director of Massachusetts General Hospital. He serves as the Chairman Emeritus of A.M. Pappas & Associates, L.L.C. and Chairman of Project HOPE. He serves as Chairman of Foundation For The National Institutes Of Health ...

Read Full Background

Corporate Headquarters*

200 Harvard Mill Square
Wakefield, Massachusetts 01880

United States

Phone: 781-246-3343
Fax: 781-246-5903

Board Members Memberships*

Chairman of the Board
Member of Board of Managers
Lead Director
Director and Member of Compensation Committee


Bachelor's Degree
University of Texas Southwestern Medical Center - Dallas
University of Texas Southwestern Medical Center - Dallas

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EDGW:US $7.29 USD +0.0799


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EDGEWATER TECHNOLOGY INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at